Proteome Sciences plc (AIM:PRM)
3.700
-0.360 (-8.87%)
Mar 26, 2025, 8:00 AM GMT+1
Proteome Sciences Revenue
Proteome Sciences had revenue of 2.22M GBP in the half year ending June 30, 2024, a decrease of -31.64%. This brings the company's revenue in the last twelve months to 4.04M, down -47.92% year-over-year. In the year 2023, Proteome Sciences had annual revenue of 5.03M, down -35.37%.
Revenue (ttm)
4.04M
Revenue Growth
-47.92%
P/S Ratio
2.97
Revenue / Employee
115.29K
Employees
35
Market Cap
11.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
Dec 31, 2019 | 4.66M | 1.61M | 52.71% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Proteome Sciences News
- 4 weeks ago - AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline - The Armchair Trader